ClinicalTrials.gg
RecruitingNCT07135336Updated Aug 22, 2025

Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment

An observational study in Cognitive and Behavioral Impairment, sponsored by Peking University Shenzhen Hospital. Recruiting at 1 site in China. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Peking University Shenzhen Hospital · Observational

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
340
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Postoperative Cognitive Complications with a site in China — 14 open to participants now, 16 under way, none of them phase 3. Postoperative Cognitive Complications · China.

Planned enrollment
7th of 24
340 · median 213
Started
2025
with 3 others
Observational
24 of 57
7 open now
Primary completion
2027-01
later than 11 of 15 live
Registered
51st of 57
by date

Among the 57 studies in Postoperative Cognitive Complications with a site in China, this one is the 7th largest by planned enrollment of the 24 observational ones that give a count, is one of 4 that started in 2025, is one of 24 observational ones, reaches primary completion later than 11 of the 15 other live ones, and was the 51st registered.

Postoperative Cognitive Complications

261 studies on the registry are indexed under Postoperative Cognitive Complications; 56 are open to participants now.

Browse Postoperative Cognitive Complications studies →

Open to participants now

14 of the 57 studies in Postoperative Cognitive Complications with a site in China are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 34 Postoperative Cognitive Complications studies recruiting now, 22 (65%) set no upper age limit and 4 (12%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Postoperative Cognitive Complications with a site in China, or all of them as a file.
02

Study summary

This study aims to find out how often memory and thinking problems happen after surgery in people who already have memory issues before their operation. These memory problems are called postoperative cognitive decline (POCD). Older adults with memory problems before surgery may be more likely to have trouble with thinking, memory, and daily activities after their operation. This study will follow patients who already have memory problems before surgery and see how their thinking and memory change after surgery. The results will help doctors better understand how to care for these patients before, during, and after surgery.

Read the detailed description

This is a single-center, prospective, single-arm cohort study designed to estimate the incidence of postoperative cognitive decline (POCD) in patients aged 60 years and older with preexisting cognitive impairment undergoing elective non-cardiac surgery under general anesthesia.

To calculate the incidence of POCD, a normative population of cognitively normal individuals will be recruited to provide reference data for the expected range of cognitive change over time in the absence of surgery. This normative sample is not a control group for intervention comparison but is used to establish population-based norms for cognitive test score changes.

Study Procedures:

Preoperative assessment (1 day before surgery):

Patients will be screened using the Mini-Cog test. Those with scores ≤1 will be further evaluated with the Mini-Mental State Examination (MMSE) and Beijing version of the Montreal Cognitive Assessment (MoCA-B).(This threshold is based on the Chinese expert consensus scoring criteria, which differ slightly from the international standard. According to the Chinese algorithm, a score of ≤1 encompasses cases where the clock drawing is incorrect and one to two words are recalled, or when no words are recalled at all, aligning functionally with a score of ≤2 in the international system. Therefore, our inclusion criterion of ≤1 under the Chinese system is equivalent in diagnostic implication to the widely accepted international cutoff of ≤2, which indicates high likelihood of cognitive impairment.) Eligible participants will be enrolled after informed consent is obtained. Neuropsychiatric symptoms will be assessed using the Neuropsychiatric Inventory-Questionnaire (NPI-Q). Dementia severity and functional ability will be evaluated using the Clinical Dementia Rating (CDR), Basic Activities of Daily Living (BADL), and Instrumental Activities of Daily Living (IADL) scales.

Intraoperative data collection:

Information regarding surgery and anesthesia will be obtained from the electronic medical records.

Postoperative follow-up (at 3 and 12 months):

All participants will undergo cognitive assessments using the MMSE and MoCA-B. Neuropsychiatric symptoms, dementia severity (if applicable), and functional abilities will also be reassessed. Follow-up will be scheduled to minimize participant burden, and home-based assessments will be arranged when necessary. Remote assessments will be documented if used.

Normative Population:

Cognitively normal individuals will be recruited from inpatients and outpatients of Peking University Shenzhen Hospital. They will undergo cognitive assessments at baseline, 3 months, and 12 months to provide normative data for the calculation of standardized cognitive changes.

Primary Outcome:

The primary outcome is the incidence of POCD at 3 months after surgery. Following the nomenclature recommendations by Evered et al., POCD is defined as objectively measurable cognitive decline occurring between 3 months and 7.5 years after surgery. The diagnosis of POCD in this study will be based on the Reliable Change Index (RCI), a standardized statistical method that accounts for normal variability and practice effects over time.

RCI is calculated as:

RCI = (ΔX_patient - Δμ_normative) / σ_normative

Where ΔX_patient is the individual's change score, Δμ_normative is the mean change in the normative group, and σ_normative is the standard deviation of change scores in the normative group.

A patient will be considered to have POCD if either:

At least two cognitive domains show an RCI ≤ -1.96, or

The combined Z-score of all cognitive tests is ≤ -1.96.

Follow-up Management and Missing Data Handling:

Participants will be followed at 3 and 12 months. If a participant is unable to attend, alternative arrangements will be made. Loss to follow-up will be documented with reasons, and missing data will be addressed using sensitivity analyses.

03

Conditions studied

  • Cognitive and Behavioral Impairment

Keywords

  • postoperative cognitive decline
  • preexisting cognitive impairment
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients aged 60 years and older with preexisting cognitive impairment undergoing elective non-cardiac surgery under general anesthesia at Peking University Shenzhen Hospital will be recruited between June 2025 and December 2027. A normative reference group of cognitively normal elderly individuals, matched by age and sex, will also be enrolled from the same hospital during the same period. All participants must reside in Shenzhen and be able to communicate in Mandarin.

Eligibility criteria

  1. Preexisting Cognitive Impairment (PreCI) Surgical Group

    Inclusion Criteria:

    • Age ≥ 60 years
    • Preoperative screening with and MoCA-B indicating mild cognitive impairment (MCI) or mild dementia
    • Undergoing elective non-cardiac surgery under general anesthesia

    Exclusion Criteria:

    • Expected difficulty in completing neuropsychological assessments (e.g., inability to communicate in Mandarin, blindness, or deafness)
    • Usual residence outside Shenzhen
  2. Normative Reference Group

Inclusion Criteria:

  • Age ≥ 60 years
  • No history of general anesthesia surgery within the past 12 months
  • Mini-Cog score > 1

Exclusion Criteria:

  • Planned elective surgery under general anesthesia within the next 12 months
  • History of suspected or diagnosed cognitive impairment, or screening indicating cognitive impairment using MMSE and MoCA-B
  • Expected difficulty in completing neuropsychological assessments (e.g., inability to communicate in Mandarin, blindness, or deafness)
  • Usual residence outside Shenzhen
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
340 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Preexisting Cognitive Impairment (PreCI) Group

    Patients aged 60 years and older with preexisting cognitive impairment undergoing elective non-cardiac surgery under general anesthesia. These patients will receive standard perioperative care without any additional intervention. Cognitive function and neuropsychiatric status will be assessed before surgery, and at 3 and 12 months after surgery to determine the incidence of postoperative cognitive decline (POCD).

    Procedure: surgery

  • Normative Population

    Cognitively normal individuals recruited from inpatients and outpatients of Peking University Shenzhen Hospital. These participants will not undergo surgery but will complete the same cognitive assessments at baseline, 3 months, and 12 months. The normative data will be used to calculate the Reliable Change Index (RCI) for identifying clinically significant cognitive decline in the PreCI group.

    Other: norma

Interventions

  • Proceduresurgery

    Patients with preexisting cognitive impairment undergoing elective non-cardiac surgery under general anesthesia.

  • Othernorma

    Cognitively normal individuals who do not undergo surgery but complete the same cognitive assessments at baseline, 3 months, and 12 months for normative reference.

06

What researchers measure

Primary outcomes

  1. Incidence of Postoperative Cognitive Decline (POCD) at 3 Months

    The primary outcome is the incidence of objectively measurable postoperative cognitive decline (POCD) at 3 months in patients with preexisting cognitive impairment undergoing elective non-cardiac surgery under general anesthesia. The diagnosis of POCD will follow the nomenclature recommendations by Evered et al., which define POCD as cognitive decline occurring between 3 months and 7.5 years after surgery, determined by standardized score changes compared with a normative reference population. In this study, POCD will be identified using the Reliable Change Index (RCI), calculated as: RCI = (ΔX\_patient - Δμ\_normative) / σ\_normative A patient will be diagnosed with POCD if: At least two cognitive domains show an RCI ≤ -1.96, or The combined Z-score of all cognitive tests is ≤ -1.96.

    Time frame: 3 months after surgery

Secondary outcomes

  1. Incidence of POCD at 12 Months

    Incidence of objectively measurable POCD at 12 months postoperatively, assessed using the same criteria as the primary outcome (RCI method).

    Time frame: 12 months after surgery

  2. Neuropsychiatric Symptoms Assessed by NPI-Q

    Neuropsychiatric symptoms will be evaluated using the Neuropsychiatric Inventory-Questionnaire (NPI-Q), based on caregiver or informant reports. It assesses the presence, severity, and caregiver distress associated with 12 neuropsychiatric symptoms commonly seen in patients with cognitive impairment. For each symptom, severity is rated on a scale from 1 to 3 (1 = mild, 2 = moderate, 3 = severe), with a total severity score ranging from 0 to 36. Higher scores indicate more severe neuropsychiatric symptoms.

    Time frame: 3 and 12 months after surgery

  3. Functional Ability Assessed by The Barthel Index

    The Barthel Index (BI) in an informant report was used for measuring basic ADL actual performance in this study. The BI is a questionnaire that consists of ten items: feeding, bathing, grooming, dressing, bowels, bladder, toilet use, transfer, mobility, and stairs. The summary score ranges from 0 to 100, with lower scores indicating a poorer basic ADL performance

    Time frame: 3 and 12 months after surgery

  4. Dementia Severity Assessed by CDR

    The Clinical Dementia Rating (CDR) will be used to assess the severity of dementia by evaluating six cognitive and functional domains. Scores range from 0 (no impairment) to 3 (severe dementia). CDR scores will be recorded at each follow-up.

    Time frame: 3 and 12 months after surgery

  5. Instrumental activities of daily living by The Lawton IADL

    Instrumental activities of daily living (IADL) will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale, a widely validated and reliable tool for evaluating functional independence in older adults. The scale includes eight domains: using the telephone, shopping, preparing meals, housekeeping, laundry, using transportation, managing medications, and handling finances. The assessment will be conducted through informant-based interviews or direct patient self-report, depending on cognitive status. Each item is scored dichotomously (0 or 1): 1 point indicates independence in performing the activity 0 points indicates dependence or inability to perform the activity. The total score ranges from 0 to 8, with higher scores indicating greater functional independence. A total score ≤6 may suggest moderate to severe functional impairment.

    Time frame: 3 and 12 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — De-identified data may be considered for sharing upon reasonable request after the study results have been published, subject to additional ethical approval.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jan 2027, 17 months after the start.

Of 76 non-industry observational studies under Postoperative Cognitive Complications, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 17 months is below that.

Counting every sponsor, half of 76 studies reached it within 27 months; a quarter within 11 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Aug 22, 2025
StartActual
Jul 15, 2025
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jul 1, 2027
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07135336
Lead sponsor
Peking University Shenzhen Hospital
Responsible party
Sponsor
First posted
Aug 22, 2025
Start date
Jul 15, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Aug 22, 2025

Study contacts

Yaqian Yu
Contact
meayaqian@gmail.com
+86 13528403653

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion